- Home
- MDIA vs CRVO Comparison
MDIA vs CRVO Comparison
Compare MDIA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- CRVO
- Stock Information
- Founded
- MDIA 2019
- CRVO 2001
- Country
- MDIA United States
- CRVO United States
- Employees
- MDIA N/A
- CRVO N/A
- Industry
- MDIA Broadcasting
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- CRVO Health Care
- Exchange
- MDIA Nasdaq
- CRVO Nasdaq
- Market Cap
- MDIA 72.4M
- CRVO 67.4M
- IPO Year
- MDIA N/A
- CRVO N/A
- Fundamental
- Price
- MDIA $1.42
- CRVO $8.85
- Analyst Decision
- MDIA
- CRVO Strong Buy
- Analyst Count
- MDIA 0
- CRVO 6
- Target Price
- MDIA N/A
- CRVO $19.17
- AVG Volume (30 Days)
- MDIA 27.0K
- CRVO 118.8K
- Earning Date
- MDIA 11-13-2025
- CRVO 11-11-2025
- Dividend Yield
- MDIA N/A
- CRVO N/A
- EPS Growth
- MDIA N/A
- CRVO N/A
- EPS
- MDIA 0.40
- CRVO N/A
- Revenue
- MDIA $121,938,000.00
- CRVO $7,776,968.00
- Revenue This Year
- MDIA N/A
- CRVO N/A
- Revenue Next Year
- MDIA N/A
- CRVO N/A
- P/E Ratio
- MDIA $3.51
- CRVO N/A
- Revenue Growth
- MDIA 165.75
- CRVO N/A
- 52 Week Low
- MDIA $0.79
- CRVO $1.80
- 52 Week High
- MDIA $2.71
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- MDIA 58.29
- CRVO 42.79
- Support Level
- MDIA $1.37
- CRVO $9.61
- Resistance Level
- MDIA $1.50
- CRVO $10.48
- Average True Range (ATR)
- MDIA 0.08
- CRVO 0.61
- MACD
- MDIA 0.01
- CRVO -0.15
- Stochastic Oscillator
- MDIA 66.67
- CRVO 6.85
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.